154 related articles for article (PubMed ID: 1380174)
1. [CD34+ cells in the autotransplant of bone marrow and peripheral blood].
Silvestri F; Baccarani M
Recenti Prog Med; 1992 Feb; 83(2):89-92. PubMed ID: 1380174
[TBL] [Abstract][Full Text] [Related]
2. Positive stem cell selection--basic science.
Civin CI; Strauss LC; Fackler MJ; Trischmann TM; Wiley JM; Loken MR
Prog Clin Biol Res; 1990; 333():387-401; discussion 402. PubMed ID: 1689854
[TBL] [Abstract][Full Text] [Related]
3. Mononuclear and CD34+ stem cell recovery after automated Ficoll processing of marrow or peripheral blood stem cells for transplantation.
Cottler-Fox M; Read EJ; Yu M; Carter C; Klein HG
Prog Clin Biol Res; 1992; 377():569-73. PubMed ID: 1279726
[No Abstract] [Full Text] [Related]
4. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
5. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
6. Purging tumor cells from bone marrow or peripheral blood using avidin-biotin immunoadsorption.
Stray KM; Corpuz S; Kalamasz D; Colter M; Berenson R; Heimfeld S
Prog Clin Biol Res; 1994; 389():97-103. PubMed ID: 7535467
[No Abstract] [Full Text] [Related]
7. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
[TBL] [Abstract][Full Text] [Related]
8. Estimation of peripheral blood CD34+ cells for autologous transplantation in cancer patients.
Siena S; Bregni M; Gianni AM
Exp Hematol; 1993 Feb; 21(2):203-5. PubMed ID: 7678809
[No Abstract] [Full Text] [Related]
9. Use of CD34+ cell fraction as a measure of hematopoietic stem cells in bone marrow and peripheral blood: comparison with the CFU-GM assay.
Janssen WE; Lee C; Farmelo MJ; Smilee R; Barth K; Fields KK; Zorsky PE; Elfenbein GJ
Prog Clin Biol Res; 1992; 377():513-21. PubMed ID: 1279719
[No Abstract] [Full Text] [Related]
10. Positive selection of bone marrow-derived CD34 positive cells for possible stem cell transplantation.
Egeland T; Tjønnfjord G; Steen R; Gaudernack G; Thorsby E
Transplant Proc; 1993 Feb; 25(1 Pt 2):1261-3. PubMed ID: 7680152
[No Abstract] [Full Text] [Related]
11. Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration.
Smiler D; Soltan M; Albitar M
Implant Dent; 2008 Sep; 17(3):236-47. PubMed ID: 18784524
[TBL] [Abstract][Full Text] [Related]
12. Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients.
Ravagnani F; Siena S; Bregni M; Brando B; Belli N; Lansdorp PM; Notti P; Pellegris G; Gianni AM
Haematologica; 1991 Mar; 76 Suppl 1():46-9. PubMed ID: 1713874
[TBL] [Abstract][Full Text] [Related]
13. Stem cell selection--clinical experience.
Berenson RJ; Bensinger WI; Hill R; Andrews RG; Garcia-Lopez J; Kalamasz DF; Still BJ; Buckner CD; Bernstein ID; Thomas ED
Prog Clin Biol Res; 1990; 333():403-10; discussion 411-3. PubMed ID: 1689855
[TBL] [Abstract][Full Text] [Related]
14. [Flow cytometry identification of CD34-positive cells].
Tichelli A; Kralj A; Huxol H; Schönenberger A; Rabaglio M; Borel J; Müller R; Bargetzi M; Gratwohl A; Signer E
Schweiz Med Wochenschr; 1995 Mar; 125(9):400-4. PubMed ID: 7534431
[TBL] [Abstract][Full Text] [Related]
15. The CD34 hemopoietic progenitor cell associated antigen: biology and clinical applications.
Silvestri F; Banavali S; Baccarani M; Preisler HD
Haematologica; 1992; 77(3):265-73. PubMed ID: 1385274
[TBL] [Abstract][Full Text] [Related]
16. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
17. Expression of differentiation-associated antigens and adhesion molecules on CD34-positive cells harvested from peripheral blood and bone marrow.
Inaba T; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Goto H; Fujita N; Nakagawa M
Prog Clin Biol Res; 1994; 389():331-7. PubMed ID: 7535439
[No Abstract] [Full Text] [Related]
18. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
[TBL] [Abstract][Full Text] [Related]
19. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
Kimlinger T; Witzig TE
Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
[TBL] [Abstract][Full Text] [Related]
20. Development of a large-scale immunomagnetic separation system for harvesting CD34-positive cells from bone marrow.
Hardwick A; Law P; Mansour V; Kulcinski D; Ishizawa L; Gee A
Prog Clin Biol Res; 1992; 377():583-9. PubMed ID: 1279728
[No Abstract] [Full Text] [Related]
[Next] [New Search]